To what extent did households in developing countries forgo needed healthcare during the COVID-19 pandemic? Repeated survey estimates from 25 countries in 2020 and 2021
BMJ Public Health · 2024-12 · 2 (2) · e001027
DOI: 10.1136/bmjph-2024-001027 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ Public Health, online erschienen am 22.12.2024. Verfasst von Jakub Kakietek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Health, Nutrition, and Population Global Practice, World Bank Group, Washington, District of Columbia, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Global Financing Facility for Women, Children and Adolescents.
Abstract (Originalsprache)
Introduction
During the first year of the COVID-19 pandemic, health system disruptions, fear of becoming infected with COVID-19, mobility restrictions and lockdowns, and reduced household incomes likely contributed to households forgoing needed healthcare. The objective of this study was to measure the prevalence of forgone healthcare and how its drivers changed between the early period of the pandemic in 2020 and the first half of 2021.
Methods
Using repeated measures collected over two time periods in 63 000 households in 25 low-income and middle-income countries, this analysis documents how the prevalence of forgone healthcare and its drivers changed between 2020 and 2021.
Results
In 2020, in the sample pooled across all countries, 17.9% of households reported not being able to obtain needed healthcare. The prevalence of forgone care was 15.6% in low-income countries (LICs), 17.0% in lower-middle-income countries (LMICs) and 20.5% in upper-middle-income countries (UMICs). In 2021, the prevalence of forgone care was lower—10.3% in the pooled sample, 7.9% in LICs, 15.1% in LMICs and 5.3% in UMICs. Financial barriers were the most common reason for not obtaining needed healthcare in both time periods: 42% in 2020 and 45% in 2021 and were higher in LICs and LMICs than in UMICs.
Conclusion
This study is a comprehensive analysis of the changes in forgone care in low-income and middle-income countries. It documents the predominance of financial barriers among those who could not obtain needed healthcare. It suggests the importance of pandemic preparedness to protect access by vulnerable households to essential healthcare service. The study also demonstrates that phone surveys could, at scale, be a cost-effective way to improve the monitoring of progress towards universal health coverage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health, Nutrition, and Population Global Practice, World Bank Group, Washington, District of Columbia, USA.
- Association of American Railroads, Washington, District of Columbia, USA.
- Program in Health Services and Systems Research, Duke-NUS Medical School, Singapore.
ORCID-Profile: Julia Dayton Eberwein
Förderung
- Global Financing Facility for Women, Children and Adolescents
Zitieren
APA
Kakietek, J., Dayton Eberwein, J., Kerr, A., & Stacey, N. (2024). To what extent did households in developing countries forgo needed healthcare during the COVID-19 pandemic? Repeated survey estimates from 25 countries in 2020 and 2021. BMJ Public Health, 2(2), e001027. https://doi.org/10.1136/bmjph-2024-001027
Vancouver
Kakietek J, Dayton Eberwein J, Kerr A, Stacey N. To what extent did households in developing countries forgo needed healthcare during the COVID-19 pandemic? Repeated survey estimates from 25 countries in 2020 and 2021. BMJ Public Health. 2024;2(2):e001027. doi:10.1136/bmjph-2024-001027
BibTeX
@article{Kakietek2024,
author = {Kakietek, Jakub and Dayton Eberwein, Julia and Kerr, Amanda and Stacey, Nicholas},
title = {To what extent did households in developing countries forgo needed healthcare during the COVID-19 pandemic? Repeated survey estimates from 25 countries in 2020 and 2021},
journal = {BMJ Public Health},
year = {2024},
volume = {2},
number = {2},
pages = {e001027},
doi = {10.1136/bmjph-2024-001027}
}
EUVIMED